Sherrod Brown on Stem Cell Research

Last Updated : Nov 04, 2012

Summary

Senator Brown supports government funding for embryonic stem cell research. He stated that the research could lead to the cure and treatment of cancer, diabetes, multiple sclerosis, Parkinson's, Alzheimer's, cancer, Lou Gehrig's Disease, and spinal cord injuries.

 

Op-Ed End the Ban on Stem Cell Research

In 2006, Congressman Brown wrote an op-ed in the Huffington Post where he described his belief that the ban on embryonic stem cell research should be lifted.

 

Stem Cell Research Enhancement Act

In April of 2007, Senator Brown spoke on the Sente floor about his support for the Stem Cell Research Enhancement Act.

 

Debate Question - Embryonic Stem Cell Research

 

Official Website Statements

 

 

Voting Record

Hope Offered through Principled and Ethical Stem Cell Research

The final piece of legislation was dubbed the "HOPE" Act and was voted on the same day. The Hope Act (S30) shared many of the same parameters as the the Stem Cell Research Act, in that it mostly ensured that no new stem cells be created for the sole purpose of using them in research. The bill also ensured that no embryos be damaged in research. Sherrod Brown voted in favor of the Hope Offered through Principled and Ethical Stem Cell Research.

Sherrod Brown voted in favor of the Hope Offered through Principled and Ethical Stem Cell Research.

Stem Cell Research Enhancement Act of 2007

In April of 2007, two more stem cell related bills were voted on in the Senate. The Stem Cell Research Enhancement Act of 2007 (S5) passed with support from a vast majority of Democratic Senators and about 1/3 of the Republican Senators. The legislation required (among other things) that any research done on stem cells involve only those which already existed. Sherrod Brown voted in favor of the Stem Cell Research Enhancement Act of 2007

Sherrod Brown voted in favor of the Stem Cell Research Enhancement Act of 2007

Stem Cell Research Enhancement Act of 2005

In 2006, an initial effort to pass a stem cell research bill through congress was also vetoed by President Bush. The veto override failed to achieve the necessary 2/3 majority.. Sherrod Brown voted in favor of overturning the veto on the Stem Cell Research Enhancement Act of 2005.

Sherrod Brown voted in favor of overturning the veto on the Stem Cell Research Enhancement Act of 2005.

The Alternative Pluripotent Stem Cell Therapies Enhancement Act

In 2006, the Senate passed the Alternative Pluripotent Stem Cell Therapies Enhancement Act. Although it was widely supported in the Senate, it did not reach the 2/3 necessary to pass the House without objection in a 273-154 vote. Sherrod Brown voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act.

Sherrod Brown voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act.

Stem Cell Therapeutic and Research Act of 2005

In 2005, Congress passed the Stem Cell Therapeutic and Research Act of 2005. The bill set up requirements for the Secretary of Health and Human Services to contract with qualified cord blood stem cell banks to assist in the '); echo('collection and maintenance of 150,000 new units of high-quality cord blood to be made available for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill passed almost unanimously in roll call 205. Sherrod Brown voted in favor of the Stem Cell Therapeutic and Research Act of 2005.

Sherrod Brown voted in favor of the Stem Cell Therapeutic and Research Act of 2005.

Stem Cell Research Enhancement Act

In May of 2005, the House passed the Stem Cell Research Enhancement Act. This legislation would have allowed research on human embryonic stem cells created after President Bush's 2001 deadline. The measure passed the House and Senate, but was vetoed. It passed the House 238-194. Sherrod Brown voted in favor of the Stem Cell Research Enhancement Act.

Sherrod Brown voted in favor of the Stem Cell Research Enhancement Act.

 

Sponsored and Cosponsored Legislation

Session-111; Bill Number-S 3751; Stem Cell Therapeutic and Research Reauthorization Act of 2010 - Cosponsor

Amends the Stem Cell Therapeutic and Research Act of 2005 to revise provisions related to the National Cord Blood Inventory (the Inventory), including to establish an inventory goal of at least 150,000 new units of cord blood to be made available under the C.W. Bill Young Cell Transplantation Program (the Program).

Session-110; Bill Number-S 5; Stem Cell Research Enhancement Act of 2007 - Cosponsor

Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements.

User Comments